Equity Analysis

Company Profile

Company News

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01023

1453.1267897

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

22.28

96742.08

EPS(TTM)

Face Value()

Div & Yield %:

260.28

0.69

Back

Callista Industries Ltd

Callista Industries Ltd - Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 & 33 Of SEBI (Listing Obligations And Disclosures Requirements) Regulations 2015.

Dec 13,2023

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that the Board of Directors of the Company at their meeting held on Wednesday 13th day of December 2023 at the registered office of the Company situated at 44 Empire Square Opp. Vidhyabharti College Baben Ta- Bardoli Surat Bardoli Gujarat India 394602 has inter- alia Considered and approved the following matters(s): 1. Considered and Approved the standalone unaudited financial results of the Company for the quarter and half year ended 30th September 2023. A copy of the said standalone unaudited financial results along with the Limited Review Report by Statutory Auditor thereon is enclosed herewith; The meeting of the Board of Directors commenced at 02:30 P.M. and concluded at 03:00 P.M.